Gefitinib is an oral targeted therapy primarily used for the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as epidermal growth factor receptor (EGFR) inhibitors, which work by blocking the signals that promote cancer cell growth. Gefitinib is particularly effective in patients with EGFR mutations, offering a personalized treatment approach that enhances survival rates and reduces tumor progression.
This medication is typically prescribed for patients with advanced or metastatic NSCLC who have shown positive results in genetic testing for EGFR mutations. It is known for its manageable side effect profile, which includes mild skin reactions, diarrhea, and fatigue. Compared to traditional chemotherapy, gefitinib offers a more targeted mechanism, minimizing damage to healthy cells and improving the overall quality of life for patients.
Several Gefitinib manufacturers ensure a steady global supply of this life-saving drug. Reliable pharmaceutical companies focus on maintaining high-quality production standards, ensuring the drug’s efficacy and safety. With continuous advancements in targeted therapy, gefitinib remains a crucial option for NSCLC patients, offering hope for improved survival and better disease management.
For those seeking Gefitinib manufacturers, it is essential to source from reputable suppliers to ensure product authenticity and regulatory compliance.